Form Bio

Amicia Elliott, Ph.D., Vice President of Product

Oct. 7 | 4:30pm | FLW Ballroom G

Austin, Texas 

(Private) 

Form Bio is the leading provider of AI/ML-powered in silico solutions that accelerate and de-risk AAV gene therapy development. We deliver data-driven insights into AAV genome integrity to identify risk profiles across the development pipeline—enabling better characterization of candidate vectors. Our proprietary models further optimize safety, efficacy, and manufacturability by enabling smarter decisions earlier in development. Together, these capabilities help teams reduce time, cost, and risk on the path to lead candidate selection.

www.formbio.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions